디지털 X선 장비 : 시장 점유율 분석, 업계 동향과 통계, 성장 예측(2026-2031년)

According to Mordor Intelligence, the digital X-ray devices market size was valued at USD 15.02 billion in 2025 and estimated to grow from USD 16.15 billion in 2026 to reach USD 23.23 billion by 2031, at a CAGR of 7.52% during the forecast period (2026-2031).

This report is Segmented by Application (Orthopedic, Dental, and More), Technology (Computed Radiography and Direct Radiography [Flat-Panel Detectors and More]), Portability (Fixed Systems and Portable Systems [Hand-Held Units and Mobile Carts]), End-User (Hospitals and More), and Geography (North America, Europe, Asia-Pacific, and More). The Market Forecasts are Provided in Terms of Value (USD).

Global Digital X-ray Devices Market Trends and Insights

Rising Prevalence of Chronic & Orthopedic Disorders

Global population aging enlarges the base of patients requiring musculoskeletal and chest imaging. Osteoporosis, osteoarthritis, and cardiopulmonary diseases now dominate outpatient diagnostics, driving regular radiographic follow-ups that create repeat equipment utilization. The World Health Organization projects that chronic disorders will account for nearly three-quarters of worldwide deaths by 2030, firmly anchoring radiography as a frontline diagnostic tool. AI-enhanced DR platforms add value by detecting subtle vertebral fractures during routine studies, as demonstrated by Nanox AI's HealthOST algorithm, which uncovered thousands of undiagnosed cases across NHS sites. Early detection lowers downstream costs and supports reimbursement for preventative imaging. Growing orthopedic imaging demand, therefore, sustains consistent unit placements across hospitals, imaging centers, and ambulatory clinics within the digital X-ray devices market.

Rapid Detector & AI Upgrades in DR Panels

Flat-panel detectors now incorporate on-board computing that improves exposure parameters, noise suppression, and automated collimation. Photon-counting architectures further enhance spatial resolution and contrast-to-noise ratios, giving clinicians more diagnostic information at lower doses. Siemens Healthineers, GE Healthcare, and other OEMs invest heavily in joint hardware-software roadmaps that extend competitive life cycles for installed fleets. GE Healthcare's collaboration with NVIDIA illustrates this pivot, aiming to automate image positioning and quality checks, thereby shortening exam times and improving technologist productivity. Facilities, therefore, prioritize detectors that can receive continuous firmware upgrades, protecting capital investments and reinforcing the digital X-ray devices market's innovation cadence.

High CAPEX & Total-Cost-of-Ownership

Premium DR rooms with advanced AI features can exceed USD 500,000, representing significant financial barriers for small hospitals. Ongoing maintenance contracts, cybersecurity upgrades, and periodic detector replacements inflate lifecycle spending. In the United States, 2025 Physician Fee Schedule adjustments cut global imaging reimbursement by 3.55%, lengthening return-on-investment horizons for new equipment. Facilities therefore scrutinize capital plans more closely, delaying some purchases and selectively favoring retrofit kits or refurbished detectors.

Other drivers and restraints analyzed in the detailed report include:

1. Cost-Savings & Dose-Reduction Versus Film/CR
2. Procurement Incentives for Retrofit Upgrades in Mid-Tier Hospitals
3. Reimbursement Gaps in Outpatient Settings

For complete list of drivers and restraints, kindly check the Table Of Contents.

Segment Analysis

Chest and pulmonary studies represented 32.21% of the digital X-ray devices market size in 2025. High examination frequency in emergency, critical-care, and routine outpatient settings sustains system utilization and encourages continuous detector upgrades. AI screening algorithms for pneumonia and tuberculosis enhance diagnostic confidence, reinforcing DR as the modality of choice for first-line respiratory evaluation. Dental imaging registers the fastest expansion at an 8.64% CAGR, helped by compact intraoral sensors and AI-assisted caries detection that streamline chairside workflows. Orthopedic imaging also climbs steadily as elderly populations require frequent fracture assessment and postoperative monitoring.

Beyond volumes, chest radiography leads AI adoption because image libraries are large and labeling is standardized, enabling rapid algorithm development. Portable chest systems deployed during infectious disease outbreaks demonstrated clear value, ensuring continuity of care while reducing cross-contamination risks. Dental practices benefit from three-dimensional reconstruction and cloud-based consults, increasing the revenue potential per visit. Together, these factors broaden the digital X-ray devices market's application mix, balancing mature high-volume segments with faster-growing specialty niches.

Direct radiography platforms captured 83.90% of digital X-ray devices market share in 2025, with continued expansion underpinned by superior image quality, workflow speed, and favorable reimbursement. Photon-counting detectors under evaluation show promise for dual-energy separation and lower dose at equal resolution, marking the next leap in detector innovation. Computed radiography remains only in budget-constrained facilities, yet escalating reimbursement penalties and the falling price of entry-level DR units drive conversion.

The digital X-ray devices industry now differentiates primarily on integrated software performance rather than raw detector pixel size. Smart acquisition protocols, predictive maintenance alerts, and automated quality assurance raise clinical confidence while reducing service costs. Consequently, procurement teams assess total software ecosystem capability before committing to hardware, cementing direct radiography's role as the technology backbone of the digital X-ray devices market.

Complete Report Scope:

• By Application
  • Orthopaedic
  • Chest / Pulmonary
  • Dental
  • Cardiovascular
  • Oncology
  • Other Applications
• By Technology
  • Computed Radiography (CR)
  • Direct Radiography (DR)
    • Flat-Panel Detectors
    • CCD/CMOS Panels
• By Portability
  • Fixed Room-Based Systems
  • Portable Systems
    • Hand-held Units
    • Mobile Carts
• By End-User
  • Hospitals
  • Diagnostic Imaging Centres
  • Ambulatory Surgical Centers (ASCs)
  • Other End-Users
• By Geography
  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • Germany
    • United Kingdom
    • France
    • Italy
    • Spain
    • Rest of Europe
  • Asia-Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • Rest of Asia-Pacific
  • Middle East and Africa
    • GCC
    • South Africa
    • Rest of Middle East and Africa
  • South America
    • Brazil
    • Argentina
    • Rest of South America

Geography Analysis

North America generated 38.10% of 2025 revenue within the digital X-ray devices market, anchored by mature hospital networks and accelerated upgrade cycles motivated by Medicare penalties. OEMs raised detector shipments after U.S. hospitals prioritized radiation safety, cybersecurity, and AI readiness in their 2025 capital budgets. Canada applies similar dose-reduction targets, while Mexico's Seguro Popular replacement scheme channels funding toward provincial imaging centers. Despite this scale, annual growth moderates to 7.05% as substitution rather than new installation dominates demand.

Asia-Pacific is the fastest-growing territory at 8.55% CAGR, propelled by multi-billion-dollar public hospital construction programs and expanding middle-class insurance coverage. China's Healthy China 2030 blueprint mandates imaging capacity expansion at county level, incentivizing regional OEMs to localize detector assembly. India's smart-city and Ayushman Bharat initiatives increase rural diagnostic reach, spurring sales of rugged portable DR. Meanwhile, Japanese and South-Korean providers purchase high-end photon-counting prototypes for cardiovascular and oncology subspecialties. Supply-chain risk in rare-earth scintillators, however, could inflate end prices if export restrictions persist, injecting volatility into Asia-Pacific procurement cycles. Europe posts a steady 7.45% CAGR to 2031 as universal health systems replace aging CR fleets. The European Radiation Protection Directive enforces dose-tracking software, elevating AI-ready DR adoption. Germany and France invest in teleradiology networks to serve rural regions, while the United Kingdom advances community diagnostic hubs that favor portable DR. Middle East & Africa demonstrates 8.02% CAGR owing to multi-clinic investments in Gulf Cooperation Council states and expanding insurance penetration in South Africa. South America grows 7.78% as Brazil's public-private concession model funds diagnostic equipment, combating historical under-supply.

1. Agfa-Gevaert
2. Analogic
3. Canon
4. Carestream Health
5. DRGEM Corporation
6. Esaote S.p.A.
7. FUJIFILM
8. GE Healthcare
9. Hitachi
10. Hologic
11. Konica Minolta
12. Koninklijke Philips
13. Lotus Healthcare
14. Mindray
15. Planmed
16. Samsung Group
17. Shimadzu
18. Siemens Healthineers
19. Skanray Technologies Limited
20. United Imaging Healthcare Co., Ltd.
21. Varex Imaging
22. Vieworks Co., Ltd.

Additional Benefits:

• The market estimate (ME) sheet in Excel format
• 3 months of analyst support

TABLE OF CONTENTS

1 Introduction

• 1.1 Study Assumptions & Market Definition
• 1.2 Scope of the Study

2 Research Methodology

3 Executive Summary

4 Market Landscape

• 4.1 Market Overview
• 4.2 Market Drivers
  • 4.2.1 Rising prevalence of chronic & orthopaedic disorders
  • 4.2.2 Rapid detector & AI upgrades in DR panels
  • 4.2.3 Cost-savings & dose-reduction versus film/CR
  • 4.2.4 Procurement incentives for retrofit upgrades in mid-tier hospitals
  • 4.2.5 Growth of point-of-care & home imaging ecosystems
  • 4.2.6 Expansion of AI-driven teleradiology networks
• 4.3 Market Restraints
  • 4.3.1 High CAPEX & total-cost-of-ownership
  • 4.3.2 Reimbursement gaps in outpatient settings
  • 4.3.3 Skilled radiographer shortage for advanced DR & AI workflows
  • 4.3.4 Supply-chain risk in rare-earth scintillators
• 4.4 Supply Chain Analysis
• 4.5 Regulatory Landscape
• 4.6 Technological Outlook
• 4.7 Porter's Five Forces Analysis
  • 4.7.1 Threat of New Entrants
  • 4.7.2 Bargaining Power of Buyers
  • 4.7.3 Bargaining Power of Suppliers
  • 4.7.4 Threat of Substitutes
  • 4.7.5 Competitive Rivalry

5 Market Size & Growth Forecasts (Value)

• 5.1 By Application
  • 5.1.1 Orthopaedic
  • 5.1.2 Chest / Pulmonary
  • 5.1.3 Dental
  • 5.1.4 Cardiovascular
  • 5.1.5 Oncology
  • 5.1.6 Other Applications
• 5.2 By Technology
  • 5.2.1 Computed Radiography (CR)
  • 5.2.2 Direct Radiography (DR)
    • 5.2.2.1 Flat-Panel Detectors
    • 5.2.2.2 CCD/CMOS Panels
• 5.3 By Portability
  • 5.3.1 Fixed Room-Based Systems
  • 5.3.2 Portable Systems
    • 5.3.2.1 Hand-held Units
    • 5.3.2.2 Mobile Carts
• 5.4 By End-User
  • 5.4.1 Hospitals
  • 5.4.2 Diagnostic Imaging Centres
  • 5.4.3 Ambulatory Surgical Centers (ASCs)
  • 5.4.4 Other End-Users
• 5.5 By Geography
  • 5.5.1 North America
    • 5.5.1.1 United States
    • 5.5.1.2 Canada
    • 5.5.1.3 Mexico
  • 5.5.2 Europe
    • 5.5.2.1 Germany
    • 5.5.2.2 United Kingdom
    • 5.5.2.3 France
    • 5.5.2.4 Italy
    • 5.5.2.5 Spain
    • 5.5.2.6 Rest of Europe
  • 5.5.3 Asia-Pacific
    • 5.5.3.1 China
    • 5.5.3.2 India
    • 5.5.3.3 Japan
    • 5.5.3.4 Australia
    • 5.5.3.5 South Korea
    • 5.5.3.6 Rest of Asia-Pacific
  • 5.5.4 Middle East and Africa
    • 5.5.4.1 GCC
    • 5.5.4.2 South Africa
    • 5.5.4.3 Rest of Middle East and Africa
  • 5.5.5 South America
    • 5.5.5.1 Brazil
    • 5.5.5.2 Argentina
    • 5.5.5.3 Rest of South America

6 Competitive Landscape

• 6.1 Market Concentration
• 6.2 Competitive Benchmarking
• 6.3 Market Share Analysis
• 6.4 Company Profiles (includes Global level Overview, Market level overview, Core Segments, Financials as available, Strategic Information, Market Rank/Share for key companies, Products & Services, and Recent Developments)
  • 6.4.1 Agfa-Gevaert N.V.
  • 6.4.2 Analogic Corporation
  • 6.4.3 Canon Medical Systems Corporation
  • 6.4.4 Carestream Health, Inc.
  • 6.4.5 DRGEM Corporation
  • 6.4.6 Esaote S.p.A.
  • 6.4.7 Fujifilm Holdings Corporation
  • 6.4.8 GE Healthcare
  • 6.4.9 Hitachi, Ltd.
  • 6.4.10 Hologic, Inc.
  • 6.4.11 Konica Minolta, Inc.
  • 6.4.12 Koninklijke Philips N.V.
  • 6.4.13 Lotus Healthcare
  • 6.4.14 Mindray Medical International Limited
  • 6.4.15 Planmed Oy
  • 6.4.16 Samsung Electronics Co., Ltd.
  • 6.4.17 Shimadzu Corporation
  • 6.4.18 Siemens Healthineers AG
  • 6.4.19 Skanray Technologies Limited
  • 6.4.20 United Imaging Healthcare Co., Ltd.
  • 6.4.21 Varex Imaging Corporation
  • 6.4.22 Vieworks Co., Ltd.

7 Market Opportunities & Future Outlook

• 7.1 White-space & Unmet-Need Assessment